Medicine and Dentistry
Glioblastoma
100%
Patient
86%
Tumor Treating Fields
66%
Surgery
66%
Skull
66%
Combination Therapy
53%
Therapeutic Procedure
43%
Recurrent Disease
37%
Adult
36%
Brain
33%
Organ
33%
Phase I Trials
33%
Hypofractionated Radiotherapy
33%
Radiation Therapy
30%
Overall Survival
24%
Neuro-Oncology
20%
Adverse Event
17%
Neoplasm
17%
Brainstem
16%
Spinal Cord
16%
Brain Tumor
16%
Toxicity
13%
Malignant Neoplasm
12%
Progression Free Survival
10%
Physician
10%
Arm
10%
Survival
10%
Chemoradiotherapy
10%
Pituitary Gland
8%
Hippocampus
8%
Optic Nerve
8%
Magnetic Resonance Imaging
8%
Gadolinium
8%
Consensus
8%
Skull Defect
7%
Bevacizumab
7%
Survival Rate
7%
Cancer Therapy
7%
Combined Therapy
7%
Follow up
6%
Pharmacology, Toxicology and Pharmaceutical Science
Glioblastoma
100%
Neoplasm
66%
Recurrent Disease
37%
Overall Survival
29%
Survival
25%
Chemoradiation Therapy
25%
Adverse Event
17%
Toxicity
13%
Progression Free Survival
10%
Chemotherapy
8%
Bevacizumab
7%
Survival Rate
7%
Study Design
6%